Announcements
Projects
Orgs
Project Post
Articles 42
Votes 0
PMLiVE
Nanoparticle-delivered RNA could deliver potential therapy for neuroinflammation - PMLiVE
>1y
Bristol Myers Squibb's Sotyktu accepted by SMC for plaque psoriasis - PMLiVE
>1y
GSK and GCOA report reveals global inequities in adult immunisation uptake - PMLiVE
>1y
Pfizer's RSV vaccine granted MHRA approval to protect infants and older adults - PMLiVE - PMLiVE
>1y
Novavax's updated COVID-19 vaccine granted Emergency Use Listing by WHO - PMLiVE - PMLiVE
>1y
WHO publishes new infodemic management tools for pandemic preparedness - PMLiVE
>1y
Pfizer and BioNTech’s COVID-19/flu combination vaccine shows promise in phase 1/2 study - PMLiVE
>1y
Differences in immune responses could optimise future COVID-19 vaccines - PMLiVE
almost2y
New EU study highlights psychological challenges of living with skin diseases - PMLiVE
almost2y
Research shows new scientific technique could halve polio detection times - PMLiVE
almost2y
Resisting the resistance - PMLiVE - PMLiVE
almost2y
Genetically altered vaccines developed to help eradicate polio - PMLiVE
~2y
UK Biobank study to review human ageing over time moves into second stage - PMLiVE - PMLiVE
~2y
MIT researchers develop AI model to detect future lung cancer risk - PMLiVE
>2y
NICE recommends wider use of statins to cut risk of heart attack and stroke - PMLiVE
>2y
First UK proton beam therapy trial launches for certain breast cancer patients - PMLiVE
>2y
New research shows potential to treat kidney disease with common medicines - PMLiVE
>2y
Genomics England receives government funding for cutting-edge genomics research - PMLiVE
>2y
ICR and University of Cambridge reveal new prostate cancer prediction tool - PMLiVE
>2y
New research shows potential to diagnose myocarditis with routine blood tests - PMLiVE
>2y
Bayer’s Nubeqa receives MHRA approval to treat metastatic prostate cancer - PMLiVE
>2y
New study links antioxidant flavonols to slower rate of memory decline - PMLiVE
>2y
ICR and The Royal Marsden reveal plans to ‘disrupt’ cancer ecosystems - PMLiVE
>2y
WHO launches R&D efforts to identify pathogens that could cause future pandemics - PMLiVE
>2y
ICR calls for further discussions following NICE’s rejection of breast cancer drug - PMLiVE
>2y